Evidence map›Paper›PMID 41217470›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

A true theranostic pair -

Naveen Kumar, Adrianna Bilinska, Elena Menéndez, Tilman Läppchen, Euy Sung Moon, Malgorzata Zoltowska, Dariusz Pawlak, Izabela Cieszykowska, Renata Mikolajczak, Frank Rösch and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Evaluation of treatment efficacy of theEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Naveen KumarDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Adrianna BilinskaDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Elena MenéndezDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Tilman LäppchenDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Euy Sung MoonDepartment of Chemistry - TRIGA site, Johannes Gutenberg University of Mainz, Mainz, Germany.
Malgorzata ZoltowskaRadioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Otwock-Świerk, Poland.
Dariusz PawlakRadioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Otwock-Świerk, Poland.
Izabela CieszykowskaRadioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Otwock-Świerk, Poland.
Renata MikolajczakRadioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Otwock-Świerk, Poland.
Frank RöschDepartment of Chemistry - TRIGA site, Johannes Gutenberg University of Mainz, Mainz, Germany.
Axel RomingerDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Eleni GourniDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. eleni.gourni@insel.ch.ORCID 0000-0003-2198-382X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study investigates the theranostic potential of a

methodsA statine-based GRPR antagonist (AAZTA

results[

conclusionThe high tumor uptake in two cancer entities with elevated expression of GRPR and the tumor response (tumor size and survival rate) highlight the significant theranostic potential of [

Indexed as

Breast NeoplasmsProstatic NeoplasmsReceptors, BombesinTheranostic NanomedicineAnimalsCell Line, TumorFemaleHumansIsotope LabelingMaleMiceSingle Photon Emission Computed Tomography Computed TomographyTissue DistributionReceptors, Bombesin44/47ScEverolimusFractionated doseGRPR antagonistmTOR inhibitor

Identifiers

PMID41217470
PMCPMC12920379

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.